Oncogenic lncRNA BBOX1-AS1 promotes PHF8-mediated autophagy and elicits sorafenib resistance in hepatocellular carcinoma.

Tao, Haisu; Zhang, Yuxin; Li, Jiang; Liu, Junjie; Yuan, Tong; Wang, Wenqiang; Liang, Huifang; Zhang, Erlei; Huang, Zhiyong

Tao, Haisu; Zhang, Yuxin; Li, Jiang; Liu, Junjie; Yuan, Tong; Wang, Wenqiang; Liang, Huifang; Zhang, Erlei; Huang, Zhiyong.

Afiliación

Tao H; Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Zhang Y; Hepatic Surgery Center, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
Li J; Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Wuhan, China.
Liu J; Hepatic Surgery Center, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
Yuan T; Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Wuhan, China.
Wang W; The First Affiliated Hospital, College of Medicine, Shihezi University, Shihezi, Xinjiang, China.
Liang H; NHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases, Beijing, China.
Zhang E; Hepatic Surgery Center, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
Huang Z; Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Wuhan, China.

Mol Ther Oncolytics ; 28: 88-103, 2023 Mar 16.

Article en En | MEDLINE | ID: mdl-36699616

Palabras clave

BBOX1-AS1; PHF8; autophagy; hepatocellular carcinoma; sorafenib resistance; tumor progression

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Ther Oncolytics Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google